Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Vivimed Labs

BSE: 532660|NSE: VIVIMEDLAB|ISIN: INE526G01021|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 26, 16:00
110.20
-4.25 (-3.71%)
VOLUME 304,748
LIVE
NSE
May 26, 15:56
110.75
-3.95 (-3.44%)
VOLUME 1,393,469
Announcements on Vivimed Labs

28th-May-2017 09:19Source: BSE

Vivimed Labs- Board recommended Dividend

Vivimed Labs Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 27, 2017,
inter alia, has recommended, subject to the approval of shareholders, payment of D...

27th-May-2017 22:52Source: BSE

Vivimed Labs- Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2017

Dear Sir / Madam,

We wish to inform you that:

1.The Board of Directors (the Board") at its meeting held today i.e. May 27, 2017 has considered and approved the Audited Financial Resu...

18th-May-2017 15:55Source: NSE

Vivimed Labs Limited

Vivimed Labs Limited has informed the Exchange regarding a press release dated May 18, 2017, titled "Vivimed announces JV partnership to grow its US Finished Dosage business, association with Strides ...

18th-May-2017 15:52Source: BSE

Vivimed Labs- Press Release

Vivimed announces JV partnership to grow its US Finished Dosage business, association with Strides Shasun aimed at building product pipelines, scale and competitiveness

18th-May-2017 15:33Source: BSE

Vivimed Labs- Outcome of Board Meeting

Outcome of the Meeting of the Board of Directors of the Company

17th-May-2017 16:06Source: BSE

Vivimed Labs- Board to consider Dividend

Vivimed Labs Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 27, 2017, inter alia, to consider and approve the audited Financial Results of the Company...

17th-May-2017 15:58Source: BSE

Vivimed Labs- Notice Of Board Meeting For Considering Audited Results For The Quarter And Year Ended 31/03/2017 And Recommend Dividend If Any, For The FY 2016-2017 & Closure Of Trading Window

With reference to the captioned subject, this is to inform you that a meeting of the Board of Directors of the Company will be held on Saturday, May 27, 2017, inter alia, to consider and approve the a...

8th-May-2017 12:07Source: BSE

Vivimed Labs- Updates

Disclosure under Regulation 31(1) & 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

3rd-May-2017 18:02Source: BSE

Vivimed Labs- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kiran Vyapar Ltd

28th-Apr-2017 12:08Source: BSE

Vivimed Labs- Updates

Disclosure under Regulation 31(1) & 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011

1 2 3 4 5 Next >>
Quick Links for Vivimed Labs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.